{
  "id": 1768146433279,
  "seqId": 77,
  "title": "Acanthamoeba Keratitis: The Resilient Opportunist",
  "summary": "Acanthamoeba keratitis is a rare but devastating protozoal infection of the cornea, primarily affecting contact lens wearers. Characterized by ubiquitous organisms capable of surviving extreme conditions, it requires early suspicion and intensive, long-term treatment to prevent irreversible vision loss.",
  "date": "2026-01-11T15:47:13.279Z",
  "data": {
    "title": "Acanthamoeba Keratitis: The Resilient Opportunist",
    "summary": "Acanthamoeba keratitis is a rare but devastating protozoal infection of the cornea, primarily affecting contact lens wearers. Characterized by ubiquitous organisms capable of surviving extreme conditions, it requires early suspicion and intensive, long-term treatment to prevent irreversible vision loss.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4'/><circle cx='100' cy='100' r='40' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2' stroke-dasharray='5,5'/><path d='M70 100 Q100 70 130 100 Q100 130 70 100' fill='hsl(215, 90%, 45%)' opacity='0.3'/><circle cx='100' cy='100' r='5' fill='hsl(215, 90%, 45%)'/><path d='M140 60 L160 40 M150 140 L170 160 M40 150 L20 170' stroke='hsl(215, 90%, 45%)' stroke-width='3' stroke-linecap='round'/></svg>",
    "sections": [
      {
        "title": "The Organism: Ubiquitous & Resilient",
        "icon": "microbiology",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Acanthamoeba Protozoa",
          "branches": [
            "Isolated from: Soil, Dust, Sea, Fresh water, Chlorinated water",
            "Free-living protozoa found everywhere",
            "Encystment: Capable of surviving unfavourable conditions",
            "Survives Extremes: Temperature, Desiccation, and pH",
            "Resistant to normal first-line broad-spectrum antibiotics"
          ]
        }
      },
      {
        "title": "Epidemiology & Impact",
        "icon": "analytics",
        "type": "chart",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": {
          "type": "bar",
          "data": [
            {
              "label": "CL use accounts for cases",
              "value": 85
            },
            {
              "label": "Req. >6mo treatment",
              "value": 50
            },
            {
              "label": "Severe vision loss/blindness",
              "value": 25
            },
            {
              "label": "Avoidable practices ID'd",
              "value": 90
            }
          ]
        }
      },
      {
        "title": "Vital Statistics",
        "icon": "info",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": "Incidence: Rare (1 per 100,000 in the EU), but rising with increased CL use and recent epidemics. Late suspicion or diagnosis can lead to devastating and irrevocable corneal scarring."
      },
      {
        "title": "Risk Factors",
        "icon": "warning",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "CL wear: especially extended-wear CL",
          "Poor CL hygiene (e.g., rinsing in tap water)",
          "Swimming with CL in situ (ponds, hot tubs, swimming pools)",
          "Corneal trauma: notably in a rural or agricultural setting"
        ]
      },
      {
        "title": "Clinical Features",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Variable symptoms: Asymptomatic, FB sensation, decreased VA, or tearing",
          "Severe pain: Often disproportionate to relatively mild clinical findings",
          "Bilateral involvement (occasionally)",
          "Epithelial ridges, pseudo- and true dendrites",
          "Stromal infiltrates (may progress circumferentially to form a ring)",
          "Perineural infiltrates",
          "Decreased corneal sensation"
        ]
      },
      {
        "title": "CRITICAL DIAGNOSTIC WARNING",
        "icon": "report_problem",
        "type": "red_flag",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "NB: Beware of missing this diagnosis!",
          "All dendritic ulcers in CL wearers should be assumed to have Acanthamoeba until proven otherwise.",
          "Avoid misdiagnosis of herpes simplex keratitis (HSK)."
        ]
      },
      {
        "title": "Complications",
        "icon": "emergency_home",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Limbal and scleral extension",
          "Corneal perforation",
          "Intractable scleritis"
        ]
      },
      {
        "title": "Investigations: Diagnostic Steps",
        "icon": "biotech",
        "type": "process",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Step 1: In vivo confocal microscopy (Direct visualization of cysts is diagnostic).",
          "Step 2: Early and adequate corneal scrapes (May deliberately debride all affected loose epithelium).",
          "Step 3: Collect samples for DNA detection (PCR), culture, and histology (fixed in 10% formalin).",
          "Step 4: Collect Contact Lenses, solutions, and cases for culture (Warn patient they will be destroyed).",
          "Step 5: Staining (Gram, Giemsa, Calcofluor white under UV light).",
          "Step 6: Culture on non-nutrient agar with E. coli overlay (25°C and 37°C, up to 14 days).",
          "Step 7: If suspicion remains despite negative tests: Corneal biopsy for culture, light and electron microscopy."
        ]
      },
      {
        "title": "Staining & Visualization",
        "icon": "colorize",
        "type": "table",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Stain Type",
            "Target"
          ],
          "rows": [
            [
              "Gram",
              "Stains organisms"
            ],
            [
              "Giemsa",
              "Stains organisms and cysts"
            ],
            [
              "Calcofluor white",
              "Stains cysts (visualized under UV light)"
            ],
            [
              "Histology",
              "10% Formalin sample"
            ]
          ]
        }
      },
      {
        "title": "Initial Treatment Protocol",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Admit patient",
          "Stop CL wear immediately",
          "Intensive hourly topical anti-amoebics: Biguanide (PHMB 0.02% or Chlorhexidine 0.02%) AND Aromatic diamidine (Propamidine isetionate 0.1% or Hexamidine 0.1%)",
          "Additional benefit: Aminoglycosides or imidazoles (oral itraconazole/fluconazole)",
          "Topical adenyl cyclase inhibitor (β-blocker): Drives resistant cysts into a susceptible protozoal state",
          "Oral analgesia and cycloplegia"
        ]
      },
      {
        "title": "Ongoing Treatment & Management",
        "icon": "history",
        "type": "remember",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "mnemonic": "Prolonged Care",
          "explanation": "Taper treatment according to improvement. Relapse is common (incomplete sterilization or reactivation of resistant intrastromal cysts). Duration: 20–40 weeks. Consider cautious topical steroids while continuing anti-amoebic agents to reduce scarring."
        }
      },
      {
        "title": "Treatment of Specific Complications",
        "icon": "healing",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Scleritis: Poor prognosis. Requires immunosuppression (systemic steroids + steroid-sparing agent like ciclosporin).",
          "Severe corneal scarring: Consider Penetrating Keratoplasty (PK) once treatment is complete and cornea is sterile.",
          "Extensive necrosis: Emergency PK (high risk of persistent/recurrent disease in grafted tissue).",
          "Severe, intractable pain: Occasionally requires enucleation."
        ]
      },
      {
        "title": "Table 7.8: Anti-amoebic Agents",
        "icon": "pill",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Class",
            "Mechanism",
            "Examples"
          ],
          "rows": [
            [
              "Aminoglycosides",
              "Inhibit protein synthesis",
              "Neomycin; paromomycin"
            ],
            [
              "Aromatic diamidines",
              "Inhibit DNA synthesis",
              "Propamidine isetionate; hexamidine"
            ],
            [
              "Biguanide",
              "Inhibit function of membrane",
              "PHMB; chlorhexidine"
            ],
            [
              "Imidazoles",
              "Destabilize cell wall",
              "Clotrimazole; fluconazole; ketoconazoles"
            ]
          ]
        }
      },
      {
        "title": "Prevention",
        "icon": "school",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Education: Focus on identifiable avoidable predisposing practices found in >90% of cases."
        ]
      }
    ]
  },
  "chapterId": "cornea",
  "_serverSynced": true
}